Common objections in pharmaceutical sales:
- High pricing or affordability concerns
- Lack of long-term safety data
- Concerns about side effects
- Resistance to switching from competitor brands

Common competitor discussion patterns:
- Doctors mention existing competitor brands they already prescribe
- Comparisons on efficacy, safety, and cost

Recommended next best actions:
- Share clinical trial or long-term safety data
- Explain patient assistance or affordability programs
- Offer follow-up meetings with additional evidence
- Provide comparative studies against competitor products
